Skip to main content
. 2022 Jul 18;13:923031. doi: 10.3389/fimmu.2022.923031

Figure 7.

Figure 7

SPINK1-regulated chemoresistance, anti-apoptosis and SPINK1-mAb targeting experiments. (A, B) SPINK1 enhanced chemoresistance in stable SPINK1-OE HepG2 and SPINK1-OE H22 cells following 24 h of exposure to 5-FU; (C) Decreased chemoresistance to 5-FU in SPINK1 knockdown Hep3B cells 24 h post-5-FU treatment. (D) Examination of apoptosis-related molecules including main pro- (Caspase 3, Bid and Bad) and anti-apoptotic regulators (Bcl-XL and Bcl-2) using Western blot in SPINK1-OE HepG2 and empty-vector control cells with or without 5-FU addition. (E, F) Targeting SPINK1 using anti-human SPINK1- mAb in SPINK1- OE H22 and - OE HepG2 cells, with IgG as an isotype control. Error bars represent mean ± standard deviation of independent experiments or the experiments performed in triplicates either in 6-well or 96-well plates. OD, optical density; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.